TY  - GEN
AU  - Johnson,Douglas B
AU  - Zhao,Fengmin
AU  - Noel,Marcus
AU  - Riely,Gregory J
AU  - Mitchell,Edith P
AU  - Wright,John J
AU  - Chen,Helen X
AU  - Gray,Robert J
AU  - Li,Shuli
AU  - McShane,Lisa M
AU  - Rubinstein,Larry V
AU  - Patton,David
AU  - Williams,P Mickey
AU  - Hamilton,Stanly R
AU  - Conley,Barbara A
AU  - Arteaga,Carlos L
AU  - Harris,Lyndsay N
AU  - O'Dwyer,Peter J
AU  - Chen,Alice P
AU  - Flaherty,Keith T
TI  - Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131)
SN  - 1557-3265
PY  - 2021///0127
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Female
KW  - Humans
KW  - Lymphoma
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - National Cancer Institute (U.S.)
KW  - Neoplasms
KW  - Oncogene Proteins, Fusion
KW  - Protein Kinase Inhibitors
KW  - therapeutic use
KW  - Proto-Oncogene Proteins B-raf
KW  - genetics
KW  - Pyridones
KW  - Pyrimidinones
KW  - Survival Rate
KW  - Treatment Outcome
KW  - United States
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1158/1078-0432.CCR-19-3443
ER  -